PurMinds NeuroPharma

Profile

PurMinds NeuroPharma is a Canadian life-science company supporting the commercialization of point-of-care testing (POCT) and decentralized diagnostic technologies. The PurMinds-SpectroChip universal lateral flow POCT platform is a portable, open-system diagnostic platform that combines rapid test kits, spectral analysis, and cloud-connected data capabilities to support accessible testing closer to the patient or field setting at hospital-level accuracy. At the core of the technology is the world’s first-of-its-kind photonic chip combining the core functionalities of spectrometry, chromatography, and lateral flow immunoassay. 

For BIO Japan 2026, PurMinds is focused on identifying Japanese partners for POCT market entry, including diagnostic and medical technology companies, distributors, clinical validation partners, and strategic commercialization partners. The company is particularly interested in applications where rapid, reliable testing can improve screening, triage, monitoring, and decentralized healthcare delivery.

Website

purminds.com

Contact


Event details

Date: October 7 - 9, 2026

Event contact

Stephen Ip
Senior International Market Consultant
Japan and Korea

Participants

13 in total